213 related articles for article (PubMed ID: 16197719)
21. Strategies to explore new approaches in the investigation and treatment of osteosarcoma.
Kim SY; Helman LJ
Cancer Treat Res; 2009; 152():517-28. PubMed ID: 20213413
[TBL] [Abstract][Full Text] [Related]
22. [Classical osteosarcoma in children and adolescent].
Rogozhin DV; Bulycheva IV; Konovalov DM; Talalaev AG; Roshchin VY; Ektova AP; Bogoroditsky YS; Strykov VA; Kazakova AN; Olshanskaya YV; Kachanov DY; Tereshchenko GV
Arkh Patol; 2015; 77(5):68-74. PubMed ID: 27077157
[TBL] [Abstract][Full Text] [Related]
23. Osteosarcoma: basic science and clinical implications.
Hayden JB; Hoang BH
Orthop Clin North Am; 2006 Jan; 37(1):1-7. PubMed ID: 16311106
[TBL] [Abstract][Full Text] [Related]
24. Future directions in the treatment of osteosarcoma.
Bishop MW; Janeway KA; Gorlick R
Curr Opin Pediatr; 2016 Feb; 28(1):26-33. PubMed ID: 26626558
[TBL] [Abstract][Full Text] [Related]
25. The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma.
Mohseny AB; Cai Y; Kuijjer M; Xiao W; van den Akker B; de Andrea CE; Jacobs R; ten Dijke P; Hogendoorn PC; Cleton-Jansen AM
Eur J Cancer; 2012 Dec; 48(18):3429-38. PubMed ID: 22868198
[TBL] [Abstract][Full Text] [Related]
26. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
Gianferante DM; Mirabello L; Savage SA
Nat Rev Endocrinol; 2017 Aug; 13(8):480-491. PubMed ID: 28338660
[TBL] [Abstract][Full Text] [Related]
27. Ewing sarcoma family of tumors.
Maheshwari AV; Cheng EY
J Am Acad Orthop Surg; 2010 Feb; 18(2):94-107. PubMed ID: 20118326
[TBL] [Abstract][Full Text] [Related]
28. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.
Salah Z; Arafeh R; Maximov V; Galasso M; Khawaled S; Abou-Sharieha S; Volinia S; Jones KB; Croce CM; Aqeilan RI
Oncotarget; 2015 Mar; 6(7):4920-35. PubMed ID: 25749032
[TBL] [Abstract][Full Text] [Related]
29. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
30. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor gene (Rb and p53) mutations in osteosarcoma.
Schreck RR
Pediatr Hematol Oncol; 1992; 9(2):ix-x. PubMed ID: 1524985
[No Abstract] [Full Text] [Related]
32. [Cytogenetics of bone sarcomas].
Vagner-Capodano AM; Poitout D
Chirurgie; 1994-1995; 120(13):188-92. PubMed ID: 8785922
[TBL] [Abstract][Full Text] [Related]
33. [The role of interleukin-11 in osteosarcoma].
Lokau J; Schoeder V; Garbers C
Pathologe; 2020 Mar; 41(2):163-167. PubMed ID: 32078699
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
[TBL] [Abstract][Full Text] [Related]
35. ErbB2 expression is correlated with increased survival of patients with osteosarcoma.
Akatsuka T; Wada T; Kokai Y; Kawaguchi S; Isu K; Yamashiro K; Yamashita T; Sawada N; Yamawaki S; Ishii S
Cancer; 2002 Mar; 94(5):1397-404. PubMed ID: 11920494
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase polymorphisms in osteosarcoma patients.
Salinas-Souza C; Petrilli AS; de Toledo SR
Pharmacogenet Genomics; 2010 Aug; 20(8):507-15. PubMed ID: 20577141
[TBL] [Abstract][Full Text] [Related]
38. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
Ren W; Gu G
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
[TBL] [Abstract][Full Text] [Related]
40. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
